Sustainability Statement

Overview

The report highlights Roche Products Australia's 2024 progress in healthcare access, clinical research and community impact. Roche medicines enabled treatment for approximately 82,000 Australians, while more than 2,390 patients enrolled in Australian clinical trials. The company achieved 100% renewable energy at all its Australian premises ahead of schedule and invested over $387,670 in the local community.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Condensed report
Fiscal year: 2024
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services